Detalhe da pesquisa
1.
Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma.
SAGE Open Med Case Rep
; 10: 2050313X221100407, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35619747
2.
Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient.
NPJ Precis Oncol
; 5(1): 5, 2021 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580193
3.
Alectinib activity in chemotherapy-refractory metastatic RET-rearranged non-small cell lung carcinomas: A case series.
Lung Cancer
; 139: 9-12, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31698333
4.
Neoadjuvant endocrine therapy in breast cancer: current role and future perspectives.
Ecancermedicalscience
; 10: 609, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26823678